GLP1
- Health
Genetic changes appear to help predict response to GLP-1 drugs for weight loss
A recent study published in Nature has revealed specific changes in two genes that may help predict whether patients will…
Read More » - Health
NIH whistleblower, GLP-1 telehealth, microbiome: Morning Rounds
Telehealth has been on the rise in recent months, with the FDA closely monitoring the marketing practices of telehealth companies…
Read More » - Health
How GLP-1 use and eating disorders intersect
GLP-1 medications have revolutionized the field of medical weight management in a remarkably short period of time. The impact of…
Read More » - Health
Why the weight, and heart risks, return after stopping GLP-1 drugs
Elizabeth Cooney, a cardiovascular disease reporter at STAT, recently covered the impact of weight loss drugs on various health conditions.…
Read More » - Top Stories
Wegovy-maker Novo Nordisk shares surge after GLP-1 pill approval
Novo Nordisk’s stock saw a significant increase of 6.9% on Tuesday following the approval of its groundbreaking GLP-1 pill by…
Read More » - Health
WHO issues guidance on GLP-1 drugs for obesity, calls them a “scientific breakthrough” and “new chapter”
The World Health Organization (WHO) has released new guidelines recommending the use of GLP-1 drugs for the treatment of obesity.…
Read More » - Health
World Health Organization Recommends GLP-1 Drugs Like Ozempic For Obesity. Here’s What To Know
The World Health Organization has recently issued global guidance on the use of GLP-1 drugs for the treatment of obesity,…
Read More » - Health
GLP-1 drugs, Tylenol Texas lawsuit, NIH: Morning Rounds
The National Institutes of Health (NIH) recently faced controversy over the changing of grant titles, despite there being no formal…
Read More » - Health
Autism research, IVF care, GLP-1 side effects: Morning Rounds
Pickleball Injuries: A Growing Concern in the Sports World Recent reports have highlighted a concerning trend in the world of…
Read More » - Health
Study finds GLP-1 drug cut migraine frequency by nearly half
GLP-1 drugs have long been known for their effectiveness in treating diabetes and obesity. However, a recent study presented at…
Read More »